Specific binding of 125I-hippocampal cholinergic neurostimulating peptide (HCNP) to rat brain membranes: Characterization and regional distribution

Brain Research

Volumn 965, Issue 1-2, 2003, Pages 194-202

  Morishita, Manabu ^a   Otsuka, Yasushi ^a   Matsukawa, Noriyuki ^a   Suzuki, Hiko ^a   Nakazawa, Hideka ^a   Maki, Mina ^a   Katou, Hideki ^a   Ueda, Ryuzou ^a   Ojika, Kosei ^a  

^a NAGOYA CITY UNIV MEDICAL SCHOOL   (Japan)

Author keywords

Distribution; Hippocampal cholinergic neurostimulating peptide; Kinetic study; Rat brain; Receptor

Indexed keywords

BRAIN PEPTIDE; HIPPOCAMPAL CHOLINERGIC NEUROSTIMULATING PEPTIDE; LIGAND; PEPTIDE FRAGMENT; RECEPTOR; UNCLASSIFIED DRUG; NEUROPEPTIDE; RADIOACTIVE IODINE;

ANIMAL TISSUE; ARTICLE; BINDING KINETICS; BRAIN MEMBRANE; CARBOXY TERMINAL SEQUENCE; CENTRAL NERVOUS SYSTEM; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISSOCIATION CONSTANT; INHIBITION KINETICS; LIGAND BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT; SCATCHARD PLOT; ANIMAL; BRAIN; CELL FRACTIONATION; CYTOLOGY; METABOLISM; PHYSIOLOGY; PROTEIN BINDING; WISTAR RAT;

ANIMALS; BRAIN; IODINE RADIOISOTOPES; NEUROPEPTIDES; PROTEIN BINDING; RATS; RATS, WISTAR; SUBCELLULAR FRACTIONS;

EID: 0037424285     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(02)04194-X     Document Type: Article

References (33)

1. 125I]containing acylating agent: application to radioimmunoassay. Biochem. J. 133:1973;529-538.
2. Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principal of protein-dye binding. Anal. Biochem. 72:1976;248-254.
3. Bylund D.B., Yamamura H.I. Methods for receptor binding. Yamamura H.I., Enna S.J., Kuhar M.J. Methods in Neurotransmitter Receptor Analysis. 1990;1-35 Raven Press, New York.
4. De Robertis E., Pellegrino De Iralde A., Rodoriguez De Lores Arnaiz G., Salganicoff L. Cholinergic and non-cholinergic nerve endings in rat brain-I. J. Neurochem. 9:1962;23-35.
5. Deliconstantinos G., Villiotou V., Stavrides J.C. Met-enkephalin receptor-mediated increase of membrane fluidity modulates nitric oxide (NO) and cGMP production in rat brain synaptosomes. Neurochem. Res. 20:1995;217-224.
6. 3H]AMPA binding sites in rat hippocampus. Br. J. Pharmacol. 115:1995;295-301.
7. Hirano A. Hirano bodies and related neuronal inclusions. Neuropathol. Appl. Neurobiol. 20:1994;3-11.
8. Iwase T., Ojika K., Matsukawa N., Nishino H., Yamamoto T., Okada H., Fujimori O., Ueda R. Muscarinic cholinergic and glutamatergic reciprocal regulation of expression of hippocampal cholinergic neurostimulating peptide precursor protein gene in rat hippocampus. Neuroscience. 102:2001;341-352.
9. Katada E., Mitake S., Matsukawa N., Otsuka Y., Tsugu Y., Fujimori O., Ojika K. Distribution of hippocampal cholinergic neurostimulating peptide (HCNP)-like immunoreactivity in organs and tissues of young Wistar rats. Histochem. Cell Biol. 105:1996;43-51.
10. Kitabgi P., Carraway R., Van Rietschoten J., Granier C., Morgat J.L., Menez A., Leeman S., Freychet P. Neurotensin: specific binding to synaptic membranes from rat brain. Proc. Natl. Acad. Sci. USA. 74:1977;1846-1850.
11. Mahadeo D., Kaplan L., Chao M.V., Hempstead B.L. High affinity nerve growth factor binding displays a faster rate of association than p140trk binding. Implications for multi-subunit polypeptide receptors. J. Biol. Chem. 269:1994;6884-6891.
12. Maki M., Matsukawa N., Yuasa H., Otsuka Y., Yamamoto T., Akatsu H., Okamoto T., Ueda R., Ojika K. Decreased expression of hippocampal cholinergic neurostimulating peptide precursor protein mRNA in the hippocampus in Alzheimer's disease. J. Neuropathol. Exp. Neurol. 61:2002;176-185.
13. Matsukawa N., Tooyama I., Kimura H., Yamamoto T., Tsugu Y., Oomura Y., Ojika K. Increased expression of hippocampal cholinergic neurostimulating peptide-related components and their messenger RNAs in the hippocampus of aged senescence-accelerated mice. Neuroscience. 88:1999;79-92.
14. Mitake S., Ojika K., Katada E., Otsuka Y., Matsukawa N., Fujimori O. Accumulation of hippocampal cholinergic neurostimulating peptide (HCNP)-related components in Hirano bodies. Neuropathol. Appl. Neurobiol. 21:1995;35-40.
15. Nomura Y., Kitamura Y., Ohnuki T., Arima T., Yamanaka Y., Sasaki K., Oomura Y. Alterations in acetylcholine, NMDA, benzodiazepine receptors and protein kinase C in the brain of the senescence-accelerated mouse: an animal model useful for studies on cognitive enhancers. Behav. Brain Res. 83:1997;51-55.
16. Ojika K., Appel S.H. Neurotrophic effects of hippocampal extracts on medial septal nucleus in vitro. Proc. Natl. Acad. Sci. USA. 81:1984;2567-2571.
17. Ojika K., Appel S.H. Neurotrophic factors and Alzheimer's disease. Katzman R. Burbury Report 15: Biological Aspects of Alzheimer's Disease. 1983;285-295 Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
18. Ojika K., Katada E., Tohdoh N., Mitake S., Otsuka Y., Matsukawa N., Tsugu Y. Demonstration of deacetylated hippocampal cholinergic neurostimulating peptide and its precursor protein in rat tissue. Brain Res. 701:1995;19-27.
19. Ojika K., Kojima S., Ueki Y., Fukushima N., Hayashi K., Yamamoto M. Purification and structural analysis of hippocampal cholinergic neurostimulating peptide. Brain Res. 572:1992;164-171.
20. Ojika K., Mitake S., Kamiya T., Kosuge N., Taiji M. Two different molecules, NGF and free-HCNP, stimulate cholinergic activity in septal nuclei in vitro in a different manner. Dev. Brain Res. 79:1994;1-9.
21. Ojika K., Mitake S., Tohdoh N., Appel S.H., Otsuka Y., Katada E., Matsukawa N. Hippocampal cholinergic neurostimulating peptide (HCNP). Prog. Neurobiol. 60:2000;35-81.
22. Ojika K., Tsugu Y., Mitake S., Otsuka Y., Katada E. NMDA receptor activation enhances the release of a cholinergic differentiation peptide (HCNP) from hippocampal neurons in vitro. Dev. Brain Res. 106:1998;173-180.
23. Ojika K., Ueki Y., Mitake S., Tsugu Y., Otsuka Y., Katada E. Demonstration of the biological activity of peptide fragments related to human and rat hippocampal cholinergic neurostimulating peptide (HCNP). Neurosci. Lett. 215:1996;127-130.
24. Otsuka Y., Ojika K. Demonstration and characterization of hippocampal cholinergic neurostimulating peptide (HCNP) processing enzyme activity in rat hippocampus. Neurochem. Res. 21:1996;369-376.
25. 3H]muscimol to membranes from dendrodendritic synaptosomes of the rat olfactory bulb. J. Neurochem. 39:1982;1381-1386.
26. Schütz W. The pharmacological basis of receptor binding. Wien. Klin. Wochenschr. 103:1991;438-442.
27. Stach R.W., Lyons C.R., Perez-Polo J.R. Characteristics of partially purified nerve growth factor receptor. J. Neurochem. 49:1987;1280-1285.
28. Taiji M., Tohdoh N., Ojika K. Neuronal expression of hippocampal cholinergic neurostimulating peptide (HCNP)-precursor mRNA in rat brain. J. Neurosci. Res. 45:1996;202-215.
29. Thoenen H. Neurotrophins and neuronal plasticity. Science. 270:1995;593-598.
30. Tohdoh N., Tojo S., Agui H., Ojika K. Sequence homology of rat and human HCNP precursor proteins, bovine phosphatidylethanolamine-binding protein and rat 23-kDa protein associated with the opioid-binding protein. Mol. Brain Res. 30:1995;381-384.
31. Tohdoh N., Tojo S., Kimura M., Ishii T., Ojika K. Mechanism of expression of the rat HCNP precursor protein gene. Mol. Brain Res. 45:1997;24-32.
32. Tsugu Y., Ojika K., Matsukawa N., Iwase T., Otsuka Y., Katada E., Mitake S. High levels of hippocampal cholinergic neurostimulating peptide (HCNP) in the CSF of some patients with Alzheimer's disease. Eur. J. Neurol. 5:1998;561-569.
33. Yuasa H., Ojika K., Mitake S., Katada E., Matsukawa N., Otsuka Y., Fujimori O., Hirano A. Age-dependent changes in HCNP-related antigen expression in the human hippocampus. Dev. Brain Res. 127:2001;1-7.